As part of the ClearView Healthcare Partners leadership team, Philip works with clients to support decision-making and pursue strategic growth. His project experience includes all major therapeutic areas, providing broad perspective on opportunities for biopharmaceutical innovation.
Philip has 10 years of experience in biopharmaceutical-related research and consulting, and believes that strategy in the life sciences space requires a combination of scientific and clinical understanding paired with a strategic commercial perspective. He and his project teams work with clients to identify expected evolution in clinical paradigms, future competition, and reimbursement and regulatory dynamics to optimize decision-making across all phases of development and commercialization.
Philip earned his B.A. in biochemical sciences from Harvard University and received his M.Sc. in molecular medicine from University College London.
Debbi Amanti Belanger
Vini De Nadai